The Berlin Institute of Health (BIH) Center for Regenerative Therapies (BCRT) and the Cluster Health Capital are jointly organising the sixth international RegMed Forum. This year, the opportunity to actively participate online will be made available.
The novel corona virus still poses great challenges worldwide, and although our understanding of Coronavirus Disease 2019 (COVID-19) is growing, many details of the disease and its association with heart disease are still unknown.
In this year’s RegMed forum, clinical scientists will give an update on COVID-19 and its relationship to heart diseases. This will be followed by scientists from academia and industry presenting and discussing novel diagnostics and regenerative treatment approaches, such as cell therapies and supportive medical devices.
The last part of the event will be dedicated to an open panel discussion, both between the scientists and with the audience.
What can you expect?
- Conference program including talks on the latest scientific findings and clinical experiences related to virus-associated heart diseases, with the main focus on COVID-19-related heart disease
- Industry presentations of technologies from national and international enterprises
The RegMed Forum is an open access conference, participation is free of charge.
Registration opens on 30 July 2020